多囊卵巢综合征对骨骼健康的负面影响:系统综述与荟萃分析
该系统综述与荟萃分析检索1990年1月1日至2018年10月9日数据库,纳入23项研究,其中21项含31383例多囊卵巢综合征(PCOS)患者和102797例对照。体重指数(BMI)<27 kg/m2的PCOS患者全股骨和脊柱骨密度(BMD)低于对照,骨钙素降低;BMI≥27 kg/m2者无差异。骨折风险仅3项研究,风险比(HR)未显示差异。作者认为PCOS骨骼参数可能部分与肥胖相关,需进一步前瞻性研究明确骨折风险。
要点
- BMI<27 kg/m2的PCOS患者全股骨和脊柱BMD低于对照。
- BMI<27 kg/m2的PCOS患者骨钙素显著降低,BMI≥27 kg/m2者无差异。
- 骨折风险仅3项研究,HR未显示PCOS与对照有差异。
核心结论
- 基于现有证据,BMI<27 kg/m2的PCOS可能与脊柱和股骨BMD降低及骨形成减少(表现为循环骨钙素水平降低)相关。
- 这些发现提示PCOS的骨骼参数可能在某种程度上与肥胖相关。
- 作者认为需进一步前瞻性研究以明确PCOS女性骨折风险是否增加。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、EMBASE和Cochrane数据库1990年1月1日至2018年10月9日的文献。
- 纳入年龄>18岁、按鹿特丹共识、雄激素过多学会、美国国立卫生研究院共识或国际疾病分类诊断PCOS的女性研究。
- 共检索921项研究,去除31项重复研究,经标题和摘要筛选后80项全文阅读,23项纳入定性合成。
- 除1项研究外,其余研究基于纽卡斯尔-渥太华量表(NOS;评分≥6)均视为高质量。
- 对21项研究进行荟萃分析,共31383例PCOS女性和102797例对照。
主要发现
- BMI<27 kg/m2的PCOS患者全股骨BMD平均差(MD)为-0.04(95%CI -0.07至0.00;I²=31%;P=0.22),脊柱MD为-0.07(95%CI -0.13至-0.01;I²=70%;P<0.01),均低于对照。
- BMI≥27 kg/m2的PCOS患者与对照相比,全股骨MD为0.02(95%CI -0.02至0.05;I²=20%;P=0.29),脊柱MD为0.02(95%CI -0.06至0.05;I²=0%;P=0.84),均无差异。
- BMI<27 kg/m2的PCOS患者骨钙素标准化平均差(SMD)为-2.68(95%CI -4.70至-0.67;I²=98%;P<0.01),显著降低;BMI≥27 kg/m2者PCOS与对照无差异。
- 仅3项研究涉及PCOS女性骨折发生率,总骨折风险比(HR)未显示PCOS与对照有差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 仅3项研究涉及PCOS女性骨折发生率。
- 纳入研究均为已达成峰值骨量的绝经前女性。
- 作者认为需进一步前瞻性研究以明确PCOS女性骨折风险是否增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Polycystic ovary syndrome (PCOS) has reproductive and metabolic aspects that may affect bone health. Controversial results from different studies regarding the risk of fractures, bone mineral density (BMD) or bone markers led to uncertainty whether PCOS might improve or deteriorate bone health. OBJECTIVE AND RATIONALE: This study aimed to investigate the impact of PCOS on bone markers, BMD and fracture risk. SEARCH METHODS: A systematic review and a meta-analysis were carried out. PubMed, EMBASE and Cochrane databases were searched for eligible studies from 1st of January of 1990 to 9th of October of 2018. Eligible studies enrolled women older than 18 years with PCOS, which should be diagnosed according to the Rotterdam Consensus, the Androgen Excess Society, the National Institutes of Health Consensus or the International Classification of Diseases. The studies were grouped according to patient mean BMI: <27 kg/m2 or ≥27 kg/m2. The results were polled as mean difference (MD), standardized MD (SMD) and hazard ratio (HR). OUTCOMES: Overall, 921 studies were retrieved, and 31 duplicated studies were removed. After screening the titles and abstracts, 80 studies were eligible for full text reading. Of those, 23 studies remained for qualitative synthesis. With the exception of one study, all studies were considered high quality based on the Newcastle-Ottawa scale (NOS; score ≥6). Meta-analysis was performed in 21 studies, with a total of 31 383 women with PCOS and 102 797 controls. Women with PCOS with BMI <27 kg/m2 had lower BMD of the total femur (MD, -0.04; 95% CI, -0.07 to 0.00; I2 = 31%; P = 0.22) and spine (MD, -0.07; 95% CI, -0.13 to -0.01; I2 = 70%; P < 0.01) when compared with the control group, whereas for women with BMI ≥27 kg/m2 no difference was observed (femur: MD, 0.02; 95% CI, -0.02 to 0.05; I2 = 20%, P = 0.29; spine: MD, 0.02; 95% CI, -0.06 to 0.05; I2 = 0%; P = 0.84). Osteocalcin was remarkably reduced in women with PCOS with BMI <27 kg/m2 (SMD, -2.68; 95% CI, -4.70 to -0.67; I2 = 98%; P < 0.01), but in women with BMI ≥27 kg/m2, there were no differences between PCOS and controls. Few studies (n = 3) addressed the incidence of bone fractures in women with PCOS. The HR for total bone fractures did not identify differences between women with PCOS and controls. WIDER IMPLICATIONS: On the basis of the available evidence, it is possible to assume that PCOS in women with BMI <27 kg/m2 is associated with reduced BMD in the spine and femur, and decreased bone formation, as manifested by lower levels of circulating osteocalcin. These findings suggest that bone parameters in PCOS may be linked, to some extent, to adiposity. These studies included premenopausal women, who have already achieved peak bone mass. Hence, further prospective studies are necessary to clarify the existence of increased risk of fractures in women with PCOS.
引用
- Piovezan JM, Premaor MO, Comim FV, et al. Negative impact of polycystic ovary syndrome on bone health: a systematic review and meta-analysis. Hum Reprod Update. 2019. PMID: 31374576. doi:10.1093/humupd/dmz020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。